Cargando…
CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
BACKGROUND: Familial hypercholesterolemia (FH) is one of the most common genetic disorders, which leads to premature coronary artery disease (CAD). It has been suggested that heterozygous FH affects around 1:250 to 1:500 in the general population or even more than this, and homozygous FH affects 1:1...
Autores principales: | Vaseghi, Golnaz, Arabi, Sina, Haghjooy-Javanmard, Shaghayegh, Sabri, Mohammadreza, Sadeghi, Masoumeh, Khosravi, Alireza, Zarfeshani, Sonia, Sarrafzadegan, Nizal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679656/ https://www.ncbi.nlm.nih.gov/pubmed/31440286 http://dx.doi.org/10.22122/arya.v15i2.1899 |
Ejemplares similares
-
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021) -
Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
por: Vaseghi, Golnaz, et al.
Publicado: (2021) -
Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia
por: Vaseghi, Golnaz, et al.
Publicado: (2022) -
Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023) -
Effects of selenium intake on the expression of prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2) and matrix metallopeptidase-9 genes in the coronary artery disease: Selenegene study, a double-blind randomized controlled trial
por: Gharipour, Mojgan, et al.
Publicado: (2021)